(Press-News.org) Promising results from a trial of a new stem-cell based therapy for a rare and debilitating skin condition have been published in the Journal of Investigative Dermatology. The therapy, involving infusions of stem cells, was found to provide pain relief and to reduce the severity of this skin condition for which no cure currently exists.
The clinical trial, led by King's College London in collaboration with Great Ormond Street Hospital (GOSH), recruited 10 children with recessive dystrophic epidermolysis bullosa (RDEB).
RDEB is a painful skin disease in which very minor skin injury leads to blisters and poorly healing wounds. About 1,000 people in the UK live with RDEB. The fragile skin in RDEB also scars, develops contractures and is prone to life-shortening skin cancers. There is currently no cure for RDEB.
The Phase I/II EBSTEM trial, funded by the Sohana Research Fund with donations from Goldman Sachs Gives, tested the safety of the treatment and also sought to establish whether it could help to reduce the severity of the disease and improve quality of life for these patients.
During the first six months of the trial, participants were given three infusions of mesenchymal stromal cells (stem cells) grown from the bone marrow of unrelated donors. Mesenchymal stem cells (MSCs) have been shown to home to wounded tissue and mediate wound healing in previous studies. Although the cells do not survive permanently, they may still deliver clinical benefits.
The children were then monitored for a year after the cell infusions. A range of monitoring tests showed no serious adverse effects in patients who received the therapy. The pain score (level of pain) reported was on average lower than before treatment, and the severity of the condition was also reported to have lessened following the infusions. Parents also reported better wound healing, less skin redness and fewer blisters.
Overall, the paper concludes that the outcomes of the trial are promising, although this is an unblinded study of participants which may introduce a positive bias in the information reported. In interviews families reported a range of benefits from having better sleep, a parent being able to return to work part-time because of reduced caring needs, and a family being able to plan their first vacation together.
However, further work is needed to better understand the mechanisms involved - for example, whether the stem cells trigger the production of a variety of growth factors and cytokines - immune system regulators - to stimulate wound healing and reduce inflammation in the skin. Further studies are also needed to confirm the efficacy of the treatment and establish the optimal dose of cells to give RDEB patients.
Dr Gabriela Petrof, lead author from St John's Institute of Dermatology at King's College London, said: 'We found that wound healing improved in all 10 children and the skin was less inflamed. Many of the kids also mentioned their skin was less painful and itchy, and their parents noted how much more energetic they were.'
Professor John McGrath, senior author from St John's Institute of Dermatology at King's College London and honorary consultant dermatologist at Guy's and St Thomas' NHS Foundation Trust, added: 'In 25 years of my research on RDEB, this is the only time I have seen any treatment change the nature of the condition. The outcomes are truly impressive and injecting the MSCs raised no safety concerns. At the same time, it's important to note that this is not a cure and that the benefits wear off after about six months.'
'Moving forward, we are now starting to introduce repeated infusions of MSCs into routine NHS clinical care. But we are also starting new clinical trials - combining cell and gene therapy to give patients with RDEB, children and adults, even better treatments as we search for a cure for this devastating inherited skin condition.'
Dr Anna Martinez, principal investigator from Great Ormond Street Hospital, said: 'Giving the cells is straightforward, but we now have to fine tune the optimal dose and interval between infusions whilst work continues on more long term-therapies.'
INFORMATION:
The study was also supported by the UK National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London.
MicroRNA can serve as a "decoder ring" for understanding complex biological processes, a team of New York University chemists has found. Their study, which appears in Proceedings of the National Academy of Sciences, points to a new method for decrypting the biological functions of enzymes and identifying those that drive diseases.
The research focuses on a particular class of enzymes that biosynthesize carbohydrates (i.e. glycans)--complex biological molecules controlling multiple aspects of cell biology--as well as on their attendant microRNA (miRNA), which are regulatory ...
MADISON - A century spent treating wildfires as emergencies to be stamped out may have cost Central Wisconsin a natural setting that was common and thriving before the state was settled.
Pine barrens once stretched like a scarf around the state's neck, from the northeast down across Central Wisconsin and up again northwest to Lake Superior. As recently as the 1950s, University of Wisconsin-Madison surveys conducted by botany Professor John Curtis and graduate student James Habeck described the sandy, open spaces dotted with pin oak and jack pine and dashed with the lavender ...
MADISON - Portable electronics - typically made of non-renewable, non-biodegradable and potentially toxic materials - are discarded at an alarming rate in consumers' pursuit of the next best electronic gadget.
In an effort to alleviate the environmental burden of electronic devices, a team of University of Wisconsin-Madison researchers has collaborated with researchers in the Madison-based U.S. Department of Agriculture Forest Products Laboratory (FPL) to develop a surprising solution: a semiconductor chip made almost entirely of wood.
The research team, led by UW-Madison ...
Boulder, Colo., USA - Lithosphere articles posted 13 and 21 May cover several fascinating locations and geodynamic processes. One study investigates the kinematic evolution of the Himalayan orogen at a site in Nepal. Another paper addresses the "unroofing" of the Klamath Mountains in northern California/southern Oregon, USA. In the East African Rift area, researchers are examining how vegetation mediates slope erosion. Another group focusses on the largest salt lake of the Mediterranean region, Lake Tuz, Turkey.
All recently posted Lithosphere articles are listed below.
Abstracts ...
Stem cell transplant is essential in the care of many blood cancers, but leaves patients requiring in-home care for months after. Frequently the role of caregiver falls to family or other committed members of the patient's support network. Previous work shows dramatically increased stress in cancer caregivers, directly impacting the caregiver and indirectly impacting the cancer patient via reduced quality of care. A randomized control trial funded by the National Cancer Institute by members of the University of Colorado Cancer Center, published in the journal Bone Marrow ...
New York, NY - NYU Langone Medical Center and its Laura and Isaac Perlmutter Cancer Center will have a high profile at the 51st Annual Meeting of the American Society for Clinical Oncology (ASCO), with researchers presenting close to 30 abstracts accepted for oral, poster and publication presentations.
Leading the way are eight oral abstract and poster presentations on melanoma for which an NYU Langone researcher is either a senior, lead or contributing author. While many of these studies are multi-institutional, five poster presentations are led by the Perlmutter ...
Despite early promise of benefits, soy doesn't help lung function
Lifestyle and diet may also affect asthma control
Study highlights importance of placebo-controlled studies
CHICAGO --- Despite previous findings suggesting a link between soy intake and decreased asthma severity, a new study from Northwestern Medicine and the American Lung Association Asthma Clinical Research Network shows soy supplements do not improve lung function for patients with asthma.
The paper, published May 26 in the Journal of the American Medical Association (JAMA), highlights the ...
While most surviving spouses had more depression symptoms following the death of their partner regardless of hospice use, researchers found a modest reduction in depressive symptoms among some surviving spouses of hospice users compared with nonhospice users, according to an article published online by JAMA Internal Medicine.
The Institute of Medicine's report on improving the quality of care near the end of life highlights the need for supporting family caregivers. Core components of high-quality hospice care include counseling services for family members before and ...
Delayed clamping of the umbilical cord to help prevent iron deficiency in infancy was associated with improved scores in fine-motor and social skills in children at age 4, particularly in boys, although it was not associated with any effect on overall IQ or behavior compared with children whose cords were clamped seconds after delivery, according to an article published online by JAMA Pediatrics.
Iron deficiency is a global health issue among preschool children associated with impaired neurodevelopment that can affect cognitive, motor and behavioral abilities. Delaying ...
In an analysis that included more than 70,000 participants from 13 studies, subclinical hyperthyroidism was associated with an increased risk for hip and other fractures including spine, according to a study in the May 26 issue of JAMA. Subclinical hyperthyroidism is a low serum thyroid-stimulating hormone concentration in a person without clinical symptoms and normal thyroid hormone concentrations on blood tests.
Overt hyperthyroidism is an established risk factor for osteoporosis and fractures. Associations between subclinical thyroid dysfunction and fractures are unclear ...
